CeriBell (CBLL) vs QuidelOrtho (QDEL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
CeriBell (CBLL) has outperformed QuidelOrtho (QDEL) over the past year, gaining 99.0% versus a loss of 55.6%. CeriBell is the larger company by market cap ($872.1 million vs $815.4 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CBLL | QDEL |
|---|---|---|
| Share price | $22.73 | $11.89 |
| Market cap | $872.14M | $815.36M |
| 1-day change | -3.22% | -3.41% |
| YTD return | +7.07% | -56.90% |
| 1-year return | +98.98% | -55.58% |
| 5-year return | — | -90.40% |
| Forward P/E | — | 8.24 |
| EPS (TTM) | $-1.76 | $-15.39 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $25.63 | $35.58 |
| 52-week low | $10.85 | $9.92 |
| Distance from 52-week high | -11.32% | -66.58% |
| Analyst consensus | strong_buy | hold |
| Avg. price target upside | +25.72% | +23.38% |
| Average volume | 368.86K | 1.49M |
| Shares outstanding | 38.38M | 68.58M |
| Employees | 327 | 6,500 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CBLL has outperformed QDEL by 154.6 percentage points over the past year.
About CeriBell
CBLL stock →CeriBell, Inc. operates as a medical technology company in the United States.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 327 employees
About QuidelOrtho
QDEL stock →QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 6,500 employees
CBLL vs QDEL FAQ
Which is bigger, CeriBell or QuidelOrtho?
CeriBell (CBLL) is larger, with a market capitalization of $872.14M compared with $815.36M for QuidelOrtho (QDEL).
Which stock has performed better over the past year, CBLL or QDEL?
CBLL returned +98.98% over the past 12 months, compared with -55.58% for QDEL (price return, excluding dividends). Past performance does not predict future results.
Are CeriBell and QuidelOrtho in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Electromedical & Electrotherapeutic Apparatus for CeriBell and Biotechnology: In Vitro & In Vivo Diagnostic Substances for QuidelOrtho.